• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Threshold Pharmaceuticals Inc

+ Add to Watchlist

THLD:US

3.8300 USD 0.1900 4.73%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Threshold Pharmaceuticals Inc (THLD)

Open: 3.9900 Day's Range: 3.7800 - 4.0900 Volume: 643,612
Previous Close: 4.0200 52wk Range: 3.6700 - 6.1100 1-Yr Rtn: -16.92%

Stock Chart for THLD

No chart data available.
  • THLD:US 4.0500
  • 1D
  • 1M
  • 1Y
4.0200
Interactive THLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4900
Est. EPS (USD) (12/2014) -0.4910
Est. PEG Ratio -
Market Cap (M USD) 227.30
Shares Outstanding (M) 59.35
30 Day Average Volume 567,734
Price/Book (mrq) -
Price/Sale (ttm) 17.7271
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THLD

Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

Harold E Selick "Barry"Chief Executive OfficerTillman PearceChief Medical Officer
Stewart M KrollSenior VP:BiostatisticsMark D MatteucciSenior VP:Discovery Research
More Company Profile & Key Executives for THLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil